SLS

SELLAS Life Sciences Group Inc.

Price

$13.85

return (12m)

714.71%

p/e

-73.23

p/bv

17.27

DIVIDEND YIELD

0.00%

SLS price

SELLAS Life Sciences Group

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SLS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.53%

3 months

83.20%

1 year

714.71%

2 years

896.40%

5 years

50.38%

10 years

-99.89%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SLS

Valuation

P/E

-73.23

Sector -4.38

Industry -4.38

P/BV

17.27

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-210.66

Sector -263.09

Industry -263.09

EV/EBIT

-210.66

Sector -702.90

Industry -702.90

P/EBITDA

-67.51

Sector -4.39

Industry -4.39

P/EBIT

-67.51

Sector -4.73

Industry -4.73

P/Total Assets

16.35

Sector 1.49

Industry 1.49

P/Net Current Assets

17.64

Sector -11.70

Industry -11.70

P/Working Capital

17.62

Sector -3.19

Industry -3.19

EPS

-0.17

Sector -2.14

Industry -2.14

BVPS

0.73

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-23.59%

Sector -65.14%

Industry -65.14%

ROA

-22.33%

Sector -65.53%

Industry -65.53%

ROIC

-955.95%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

18.82

Sector 2.90

Industry 2.90

Net Debt / EBITDA

13.01

Sector -6.07

Industry -6.07

Net Debt / EBIT

13.01

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.00

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.95

Sector 0.41

Industry 0.41

Liabilities/Assets

0.05

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

9.43%

Sector -

Industry -

Fundamentals SLS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SLS SELLAS Life Sciences Group Inc.	$13.85	700.58%	0.00%	-73.23	17.27	-23.59%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SLS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT SELLAS Life Sciences Group

SELLAS Life Sciences Group Inc.

Average Investor10 user rating

4.0 (3 people)

United States

20 years

Founded: 2006

2008

Time since IPO - 18 years

7

Employees

SELLAS Life Sciences Group Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.38 billion, with shareholders equity totaling $137.66 million.

The company employs approximately 7 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, SELLAS Life Sciences Group Inc. reported $- in revenue, generating net income of $-32.47 million.

Key financial metrics include a P/E ratio of -73.23, a price-to-book (P/B) ratio of 17.27, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SLS.

Market cap

$2.38 billion

Net worth

$137.66 million

$137,660,000.00

Assets

$145.38 million

$145,380,000.00

Total Shares Outstanding

189.00 million

189,000,000

Average Daily Trading Volume

$8.37 million

$8,371,472.00

Sector

Health Care

Industry

Biotechnology

SLS

SLS revenue and profits

Financial Results SLS

DRAG THE FRAME TO SEE MORE DATA

SLS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of SELLAS Life Sciences Group (SLS) today?

A cotação de SELLAS Life Sciences Group (SLS) hoje está em US$ 13.85, com uma variação de 714.71% em relação ao último ano. A cotação de SELLAS Life Sciences Group (SLS) iniciou o ano negociando na casa dos US$ 3.77 e hoje está em US$ 13.85. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de SELLAS Life Sciences Group (SLS) e dados de ações do Ibovespa e mercados internacionais.

Quando SELLAS Life Sciences Group (SLS) paga dividendos?

SELLAS Life Sciences Group (SLS) não distribuiu dividendos no último ano.

Is SELLAS Life Sciences Group (SLS) a good investment?

Atualmente, SELLAS Life Sciences Group (SLS) está cotada a US$ 13.85, com um P/L de -73.23, representando um desvio de -1,902% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 714.71 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 714.71%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy SELLAS Life Sciences Group (SLS) stock?

Investir em ações de SELLAS Life Sciences Group (SLS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of SELLAS Life Sciences Group (SLS) yield today?

A rentabilidade de SELLAS Life Sciences Group (SLS) foi de 10.53% no último mês, 714.71% no último ano e 50.38% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de SELLAS Life Sciences Group (SLS) hoje, o investimento total seria de US$ 1,385.00, com base na cotação atual de US$ 13.85.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 11,283.73
Em 5 anos: US$ 2,082.76
Em 10 anos: US$ 1.52

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SLS

SELLAS Life Sciences Group Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SLS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SLS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT SELLAS Life Sciences Group

SELLAS Life Sciences Group Inc.

United States

20 years

2008

7

PROFIT X PRICE SLS

Financial Results SLS

SLS cash flow

Asset, Revenue and Profit Growth - SLS

SLS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions